文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛儿科与产科急症

儿童急性呼吸窘迫综合征表型的识别:一项潜在类别分析

Identification of phenotypes in paediatric patients with acute respiratory distress syndrome: a latent class analysis.
PubMed 文献 · Lancet Respir Med · 2021-12-06
一句话结论儿童ARDS存在两个表型,高炎症表型(表型2)机械通气时间更长、死亡率更高,未来临床试验设计应考虑表型。

本研究为RESTORE临床试验与BALI辅助研究的二次分析,纳入304例儿童ARDS(PARDS)患者,采用潜在类别分析识别表型。结果识别出两个类别:表型1(181例,60%)和表型2(123例,40%);表型2以炎症生物标志物浓度更高、血管加压药使用率更高、脓毒症诊断更频繁为特征,与成人高炎症表型一致。表型2患者机械通气时间更长(中位10.0天 vs 6.6天,p<0.0001),死亡率更高(13.8% vs 2.2%,p=0.0001)。使用成人表型分类算法在儿童中评估,sTNFr1+血管加压药使用+IL-6变量的AUC为0.956,sTNFr1+血管加压药使用+IL-8变量的AUC为0.954。作者认为未来儿童临床试验的设计和分析应考虑PARDS表型。

要点

  • 在304例PARDS患儿中,潜在类别分析识别出两个表型:表型1(181例,60%)和表型2(123例,40%),两类别模型优于单类别模型(p<0.001)。
  • 表型2为高炎症表型,特征为炎症生物标志物浓度更高、血管加压药使用率更高、脓毒症诊断更频繁,与成人高炎症表型一致。
  • 表型2患儿机械通气时间中位10.0天(IQR 6.3-21.0),表型1为6.6天(IQR 4.1-10.8),p<0.0001。
  • 表型2死亡率13.8%(17/123),表型1为2.2%(4/181),p=0.0001。
  • 使用成人表型分类算法在儿童中评估:sTNFr1+血管加压药使用+IL-6变量AUC为0.956,sTNFr1+血管加压药使用+IL-8变量AUC为0.954(以潜在类别分析为金标准)。

适用人群与场景

  • 纳入RESTORE临床试验和BALI辅助研究中的304例儿童ARDS(PARDS)患者,进行二次分析。

诊断标准与关键阈值

  • 采用潜在类别分析,纳入人口学、临床和血浆生物标志物变量识别PARDS表型。
  • 两类别模型优于单类别模型(p<0.001)。
  • 表型1(181例,60%)和表型2(123例,40%),表型2为高炎症表型。

研究设计与关键结果

  • 研究类型:RESTORE临床试验和BALI辅助研究的二次分析,采用潜在类别分析。
  • 样本量:304例PARDS患儿。
  • 表型2特征:炎症生物标志物浓度更高、血管加压药使用率更高、脓毒症诊断更频繁;所有PARDS严重程度在两个表型中均可见。
  • 表型2 vs 表型1:机械通气时间中位10.0天(IQR 6.3-21.0)vs 6.6天(IQR 4.1-10.8),p<0.0001;死亡率13.8%(17/123)vs 2.2%(4/181),p=0.0001。
  • 成人表型分类算法在儿童中的表现:sTNFr1+血管加压药使用+IL-6变量AUC为0.956,sTNFr1+血管加压药使用+IL-8变量AUC为0.954(以潜在类别分析为金标准)。

证据类型、等级与局限

  • 证据类型:二次分析(临床试验和辅助研究的汇总数据)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,未来儿童临床试验的设计和分析应考虑PARDS表型。

指南或共识出处

  • RESTORE临床试验和BALI辅助研究(本文为二次分析)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Previous latent class analysis of adults with acute respiratory distress syndrome (ARDS) identified two phenotypes, distinguished by the degree of inflammation. We aimed to identify phenotypes in children with ARDS in whom developmental differences might be important, using a latent class analysis approach similar to that used in adults.

METHODS: This study was a secondary analysis of data aggregated from the Randomized Evaluation of Sedation Titration for Respiratory Failure (RESTORE) clinical trial and the Genetic Variation and Biomarkers in Children with Acute Lung Injury (BALI) ancillary study. We used latent class analysis, which included demographic, clinical, and plasma biomarker variables, to identify paediatric ARDS (PARDS) phenotypes within a cohort of children included in the RESTORE and BALI studies. The association of phenotypes with clinically relevant outcomes and the performance of paediatric data in adult ARDS classification algorithms were also assessed.

FINDINGS: 304 children with PARDS were included in this secondary analysis. Using latent class analysis, a two-class model was a better fit for the cohort than a one-class model (p<0·001). Latent class analysis identified two classes: class 1 (181 [60%] of 304 patients with PARDS) and class 2 (123 [40%] of 304 patients with PARDS), referred to as phenotype 1 and 2 hereafter. Phenotype 2 was characterised by higher concentrations of inflammatory biomarkers, a higher incidence of vasopressor use, and more frequent diagnosis of sepsis, consistent with the adult hyperinflammatory phenotype. All levels of severity of PARDS were observed across both phenotypes. Children with the hyperinflammatory phenotype (phenotype 2) had worse clinical outcomes than those with the hypoinflammatory phenotype (phenotype 1), with a longer duration of mechanical ventilation (median 10·0 days [IQR 6·3-21·0] for phenotype 2 vs 6·6 days [4·1-10·8] for phenotype 1, p<0·0001), and higher incidence of mortality (17 [13·8%] of 123 patients vs four [2·2%] of 181 patients, p=0·0001). When using adult phenotype classification algorithms in children, the soluble tumour necrosis factor receptor-1 (sTNFr1), vasopressor use, and interleukin (IL)-6 variables gave an area under the curve (AUC) of 0·956, and the sTNFr1, vasopressor use, and IL-8 variables gave an AUC of 0·954, compared with the gold standard of latent class analysis.

INTERPRETATION: Latent class analysis identified two phenotypes in children with ARDS with characteristics similar to those in adults, including worse outcomes among patients with the hyperinflammatory phenotype. PARDS phenotypes should be considered in design and analysis of future clinical trials in children.

FUNDING: US National Institutes of Health.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

参考来源

  1. Dahmer MK, Yang G, Zhang M, et al. Identification of phenotypes in paediatric patients with acute respiratory distress syndrome: a latent class analysis. Lancet Respir Med. 2021. PMID: 34883088. doi:10.1016/S2213-2600(21)00382-9

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。